Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03058250
Other study ID # IRB12-1694
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 2012
Est. completion date May 2016

Study information

Verified date February 2023
Source University of Chicago
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective randomized controlled trial looking at the utility of intraoperative transesophageal echocardiography (TEE) on clinical outcomes after radical cystectomy. Patients in the control group will have standard of care, patients in the TEE group will have standard of care and TEE monitoring throughout. Intraoperative and postoperative variables, such time to extubation, postoperative cardiac and pulmonary complications, intraoperative fluid and vasopressor use will be assessed.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date May 2016
Est. primary completion date March 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patients have elective radical cystectomy at The University of Chicago Hospital. Exclusion Criteria: - Patient refusal, emergent surgery, preoperative mechanical ventilation, preoperative hemodynamic instability (intravenous vasopressor support), and/or esophageal/gastric pathology contraindicating insertion of the transesophageal echocardiography probe.

Study Design


Related Conditions & MeSH terms

  • Cardiac and Pulmonary Complications. Central Venous Line Insertion. Gastrointestinal Recovery

Intervention

Other:
Transesophageal echocardiography


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Chicago

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of intraoperative central venous line insertion 1 day after study enrollment
Primary postoperative return of bowel function via flatus or passage of stool 5 days after study enrollment
Secondary Decreased postoperative pulmonary and cardiac complications approximately 5-7 days